Imeglimin
Imeglimin is a pharmaceutical drug with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
1
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes Mellitus
Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy
Pharmacokinetics of Imeglimin in Hepatic Impaired Subjects
Bioequivalence of Imeglimin Tablet Formulations
Effect of Cimetidine on the PK of Imeglimin
Clinical Trials (8)
Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes Mellitus
Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy
Pharmacokinetics of Imeglimin in Hepatic Impaired Subjects
Bioequivalence of Imeglimin Tablet Formulations
Effect of Cimetidine on the PK of Imeglimin
Safety, Tolerability and PK of Imeglimin in Japanese Volunteers
Effect of Imeglimin on QT/QTc Intervals in Healthy Subjects
A Study of the Efficacy and Safety of 4 Doses of Imeglimin After 24 Weeks of Treatment in Subjects With Type 2 Diabetes
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8